New vaccine against malaria

The World Health Organization (WHO) has recommended a new vaccine, R21/Matrix-M, for the prevention of malaria in children.

Why didn’t people in the US get COVID-19 boosters?

More than 80% of the people in the US who were eligible to receive a COVID-19 booster last autumn did not have the jab.

Suppressing autoimmunity

Researchers have uncovered new details about how the immune system prevents the production of antibodies that can recognise and damage healthy tissues.

Unparalleled depth of data

Professor of Respiratory Research Louise Wain discusses an ongoing research project into the medium- and long-term effects of COVID.

T-cells infiltrating the brain

Cryptococcus-associated immune reconstitution inflammatory syndrome (C-IRIS) happens when an immunocompromised patient is unknowingly infected with the fungus Cryptococcus.

Debunking vaccine myths with ChatGPT

ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study.

The evolution of traditional medicine

From shamans and witches to contemporary use of medicinal plants and health tourism, Stephen Mortlock looks at traditional medicines through the ages.

Newly discovered genetic defect

In the quest to find the origin of the puzzling symptoms in four children, researchers from St. Anna Children’s Cancer Research Institute (CCRI) and the Medical University of Vienna have discovered a completely new disease, linking disruptions of blood formation, the immune system and inflammation.

Can antidepressants help prevent COVID?

New research from King’s College London has found that community mental health patients who were prescribed antidepressants were significantly less likely to test positive for COVID-19 when admitted to inpatient care.

Autoimmune diseases revisited part 2

In the first article in this series from March 2023, an outline of the history of autoimmunity and significant concepts such as immunotolerance and clonal deletion were introduced. More details of five autoimmune diseases are now presented.

The rise of point-of-care testing

Following the release of national point-of-care testing guidance, we look at the rapidly expanding sector and the vital involvement of biomedical scientists.